HNN3.0
Register
Register
Register

Project cooperationUpdated on 21 January 2026

Early detection for heart diseases with AI

Public Affairs Advisor at Lykke Advice

Brussels, Belgium

About

Representing Cardisio GmbH, founded in 2016 and headquartered in Frankfurt am Main in Germany, is committed to the early detection of heart disease. In Cardisio’s vision for the future, everyone has access to a scientifically proven, highly accurate, and non-invasive screening procedure for heart diseases that is easy to use, examiner-independent, and affordable. Our final aim is to reduce cardiac deaths, complications, and healthcare costs by providing more effective heart exams globally.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health

Type

  • Partner seeks Consortium/Coordinator

Organisation

Lykke Advice

Consultancy

Brussels, Belgium

Similar opportunities